Catheter Precision, Inc. (VTAK) financial statements and ratios from SEC XBRL: revenue $819000.00 (TTM), net margin -2098.0%, revenue growth 95.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $819000.00 |
| Net Margin | -2098.0% |
| Return on Equity | -75.9% |
| Debt / Equity | 0.56 |
| Current Ratio | 0.19 |
| Revenue Growth (YoY) | 95.0% |
| EPS Growth (YoY) | 138.0% |
| FCF Growth (YoY) | -11.0% |
| EV / EBITDA | -0.8 |
| Price / Book | 0.24 |
| Price / Sales | 2.10 |
| FCF Yield | -232.6% |
| Altman Z-Score | -31.90 (distress) |
| Sector P/E (Healthcare) | 21.6 |
VTAK overview · VTAK earnings · VTAK KPIs · VTAK investor relations · VTAK ownership · VTAK peers · VTAK filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.